Related Experiment Video
Updated: Aug 19, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Pseudomembranous colitis in children
1Department of Pediatrics, Georgetown University School of Medicine, 4431 Albemarle Street NW, Washington, DC 20016, USA. ib6@georgetown.edu
Insights
Pseudomembranous colitis (PMC) in children is often linked to antibiotic use and hospitalization, primarily caused by Clostridium difficile toxins. Treatment involves antibiotic cessation, supportive care, and sometimes oral vancomycin.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Pseudomembranous colitis (PMC) is a significant gastrointestinal condition.
- It is frequently associated with prior antibiotic exposure and hospitalization.
- Clostridium difficile toxins are the primary causative agents.
Purpose of the Study:
- To review the microbiology, management, and prevention of PMC in pediatric patients.
- To highlight the clinical spectrum and common associations of PMC.
- To provide an overview of current therapeutic strategies.
Main Methods:
- Literature review focusing on pseudomembranous colitis in children.
- Analysis of causative agents, particularly Clostridium difficile.
- Examination of clinical presentations, risk factors, and treatment outcomes.
Main Results:
- PMC incidence is lower in children but can range from mild diarrhea to severe colitis.
- Antibiotics like ampicillin, amoxicillin, cephalosporins, and clindamycin are frequently implicated.
- Most cases resolve with antibiotic discontinuation and supportive care.
Conclusions:
- Early recognition and appropriate management are crucial for pediatric PMC.
- Understanding the role of Clostridium difficile and antibiotic associations aids prevention.
- Oral vancomycin or alternative therapies may be necessary for refractory cases.
Abstract:
This review presents the microbiology, management and prevention of pseudomembranous colitis (PMC) in children. PMC is commonly associated with prior antibiotic exposure and hospitalization. It is caused almost exclusively by toxins produced by Clostridium difficile. The clinical spectrum of this disease may range from a mild, non-specific diarrhea to severe colitis with toxic megacolon, perforation, and death. PMC may affect all age groups, although a lower incidence has been noted in children. Ampicillin, amoxicillin, the second- and third-generation cephalosporins and clindamycin are the drugs most frequently associated with development of PMC, although nearly all antimicrobials have been implicated as causes of diarrhea and colitis. Discontinuation of antibiotics and supportive therapy usually lead to resolution of this disorder. Administration of oral vancomycin or other therapeutic regimens may be needed.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Giardiasis
Bacterial Gastroenteritis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...